SARS-CoV-2 transmission rate is low when following a COVID+ patient in the operating room
- 6 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Langenbecks Archiv für Chirurgie
- Vol. 406 (2), 401-404
- https://doi.org/10.1007/s00423-021-02085-0
Abstract
Acquiring SARS-CoV-2 infection for uninfected patients undergoing surgical procedures following a COVID positive (COVID+) patient is of significant concern, both for patients seeking medical care in hospital settings and for management of surgical services during pandemic times. Using data identifying all COVID+ surgical patients during the initial pandemic peak in New York City (March 15 to May 15, 2020), we analyzed the rate of postoperative symptomatic SARS-CoV-2 infection in COVID negative (COVID−) patients undergoing surgery in the same operating room within 48 h, thus determining nosocomial symptomatic infection rate attributable to COVID operating room exposure. Five COVID− patients directly followed a COVID+ patient, while 19 patients were exposed to COVID+ operating rooms within 24 h. By 48 h, 21 additional patients were exposed. No exposed patients acquired symptomatic SARS-CoV-2 infection postoperatively. With implementation of infection prevention and control procedures in the operating room under local pandemic conditions, our findings suggest that the risk of acquiring SARS-CoV-2 infection, when following a COVID+ patient in the same operating room, is very low.This publication has 5 references indexed in Scilit:
- Global guidance for surgical care during the COVID-19 pandemicBritish Journal of Surgery, 2020
- Sustainability of Coronavirus on Different SurfacesJournal of Clinical and Experimental Hepatology, 2020
- Electrocautery, Diathermy, and Surgical Energy DevicesAnnals of Surgery, 2020
- Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19)Journal of the American College of Surgeons, 2020
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1The New England Journal of Medicine, 2020